parkinson glutathione oxidative ipsc crispr Frontiers Past, present, and future of

Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses Cell Research Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Using iPS Cells toward the Understanding of Parkinson's Disease

SKU: 3497388189 · From psychiatrist-in-kuwait.com